Radiology leaders are urged to understand forthcoming CMS 2026 reimbursement changes for CCTA, FFR-CT, and AI plaque analysis.
Key Details
- 1CMS 2026 Final Rule will alter reimbursement for CCTA, FFR-CT, and AI-enabled plaque analysis.
- 2A new Category 1 code for AI-Enabled Coronary Plaque Analysis will be introduced.
- 3Webinar to educate on payment policies, projected 2026 rates, and integration of advanced analytics.
- 4Guidance provided on operational best practices, revenue codes, and managing prior authorization.
- 5Aimed at imaging administrators, coding specialists, and radiology service leaders preparing for policy shifts.
Why It Matters
These reimbursement changes will impact clinical workflows, financial planning, and access to innovative cardiac imaging technologies for radiology providers. Proactive adaptation will be key to maintaining service viability and quality care.
Source
Radiology Business
Related News
•HealthExec
AI Reimbursement, Biomedical Research, and Exec Survey Highlight Healthcare Trends
Healthcare AI adoption is rising, but ROI measurement and clinical impact remain key challenges.
•HealthExec
Senate Vote Fails to Block AI Medicare Prior Authorization Pilot
A Senate vote failed to halt the WISeR AI-based prior authorization pilot for traditional Medicare claims.
•AuntMinnie
Radiologists Struggle to Spot AI-Generated Radiology Images
Radiologists correctly identify AI-generated images 75% of the time, with CT and MRI images being particularly challenging to spot.